Published on
May 7, 2026
- 10:00 GMT
BrandLaunchX Launches AI Platform to Reduce Drug Launch Failures and Accelerate Patient Access to Approved Therapies
New platform addresses the operational gap that causes 80% of therapeutic launches to underperform, delaying patient access to approved medicines LONDON, ENGLAND, UNITED KINGDOM, May 7, 2026 /EINPresswire.com/ -- BrandLaunchX, a UK-based artificial …
Distribution channels:
Healthcare & Pharmaceuticals Industry, International Organizations
...
